Africa Finance Today
SEE OTHER BRANDS

The best finance and banking news from Africa

Africa Finance Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Finance Today.

Press releases published on April 28, 2025

Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Diluted Net Income Per Share - Adjusted of $1.29; and a…

Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Diluted Net Income Per Share - Adjusted of $1.29; and a…

DAYTONA BEACH, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- Brown …

Volatus Announces $2,000,000 Financing

Volatus Announces $2,000,000 Financing

Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to …

Volatus annonce un financement de 2 000 000 $

Volatus annonce un financement de 2 000 000 $

Interdiction de diffusion aux agences de presse américaines et de diffusion aux États-Unis. TORONTO, 28 avr. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV : FLT) (OTCQX : TAKOF) (Francfort : ABB) (« Volatus » ou la « Société ») a le plaisir d' …

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …

Trident Filed 2024 Annual Report on Form 20-F

Trident Filed 2024 Annual Report on Form 20-F

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today …

 Macerich Declares the Quarterly Dividend on Its Common Shares

Macerich Declares the Quarterly Dividend on Its Common Shares

SANTA MONICA, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on June 17, 2025, to stockholders of record …

Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

GIG HARBOR, Wash., April 28, 2025 (GLOBE NEWSWIRE) -- Heritage Distilling Holding Company, Inc. (“HDC” or “Heritage” or the “Company”) (Nasdaq: CASK), a leading craft distiller of innovative premium brands, today reported it regained compliance with the …

Ebang International Reports Financial Results for Fiscal Year 2024

Ebang International Reports Financial Results for Fiscal Year 2024

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we” or “our”), today announced its financial results for the fiscal year ended December 31, 2024. Operational and Financial Highlights for Fiscal …

Transocean Ltd. Reports First Quarter 2025 Results

Transocean Ltd. Reports First Quarter 2025 Results

  Three months ended         Three months ended         March 31,   December 31,   sequential   March 31,   year-over-year   2025   2024   change   2024   change (In millions, except per share amounts, percentages and backlog)                             …

Powell Max Limited Announces 2024 Audited Financial Results

Powell Max Limited Announces 2024 Audited Financial Results

HONG KONG, April 28, 2025 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (the “Company” or “Powell Max”), a financial communications services provider headquartered in Hong Kong, today announced the audited financial results of the Company and its …

SPAR Group, Inc. Receives Nasdaq Notice of Late Filing of its Form 10-K

SPAR Group, Inc. Receives Nasdaq Notice of Late Filing of its Form 10-K

AUBURN HILLS, Mich., April 28, 2025 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SGRP”, “SPAR Group” or the “Company”), a provider of merchandising, marketing and distribution services announced today that it received a notification letter (the “ …

Piedmont Office Realty Trust, Inc. Releases First Quarter 2025 Results

Piedmont Office Realty Trust, Inc. Releases First Quarter 2025 Results

Atlanta, April 28, 2025 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc (NYSE: PDM) has released its financial and operational results for the first quarter of 2025.  Please visit the Investor Relations section of Piedmont's website at https:// …

NXP Semiconductors Reports First Quarter 2025 Results, Announces Management Transition

NXP Semiconductors Reports First Quarter 2025 Results, Announces Management Transition

EINDHOVEN, The Netherlands, April 28, 2025 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today reported financial results for the first quarter, which ended March 30, 2025. “NXP delivered quarterly revenue of $2.84 billion, in-line with the …

Palomar Holdings, Inc. Announces First Quarter 2025 Financial Results Release Date  and Conference Call

Palomar Holdings, Inc. Announces First Quarter 2025 Financial Results Release Date and Conference Call

LA JOLLA, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (the “Company”) today announced that it will release its first quarter 2025 results after market close on Monday, May 5, 2025, and will host a conference call at 12: …

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, …

GENFIT : les données positives de la Phase 2 évaluant elafibranor dans la Cholangite Sclérosante Primitive (PSC) seront présentées en « late breaking » par Ipsen au congrès de l'EASL 2025

GENFIT : les données positives de la Phase 2 évaluant elafibranor dans la Cholangite Sclérosante Primitive (PSC) seront présentées en « late breaking » par Ipsen au congrès de l'EASL 2025

Lille (France), Cambridge (Massachusetts, Etats-Unis), Zurich (Suisse), 28 avril 2025 - GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique spécialisée dans l'amélioration de la vie des patients atteints de maladies rares du foie pouvant engager …

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

PHILADELPHIA and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel …

Financial Institutions, Inc. Announces First Quarter 2025 Results

Financial Institutions, Inc. Announces First Quarter 2025 Results

WARSAW, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (NASDAQ: FISI) (the "Company," "we" or "us"), parent company of Five Star Bank (the "Bank") and Courier Capital, LLC ("Courier Capital"), today reported financial and operational …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service